Bloomberg News

U.K. to Open First Phenome-Research Center

July 31, 2012

U.K. Prime Minister David Cameron will announce plans to transform the London Olympic anti-doping facility into a 10 million-pound ($16 million) center that studies how genes are transformed by lifestyle.

The phenome center in Harlow, northeast of London, will allow scientists to study how people respond to drugs and allow them to investigate the effects of diet, the environment and stress on the molecular make-up of individuals to develop new treatments. Cameron will announce the project, the first of its kind in the world, at a gathering of health professionals in London today.

“This will take advantage of the extraordinary opportunities that lie in combining genetic data with the results of medical tests on tissues and blood,” Cameron will say, according to remarks released by his office. “It will produce new forms of drugs and it will lead the world in the development of precision medicine.”

Facilities and equipment for the center are being provided by GlaxoSmithKline Plc (GSK), to which Bruker Corp. (BRKR:US) and Waters Corp. will also contribute.

To contact the reporter on this story: Gonzalo Vina in London at gvina@bloomberg.net

To contact the editor responsible for this story: James Hertling at jhertling@bloomberg.net


Race, Class, and the Future of Ferguson
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Companies Mentioned

  • BRKR
    (Bruker Corp)
    • $20.08 USD
    • 0.05
    • 0.25%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus